BlackRock Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$14.1M Buy
178,503
+70,159
+65% +$5.45M 0.01% 724
2016
Q3
$8.45M Buy
108,344
+36,403
+51% +$2.64M 0.01% 932
2016
Q2
$4.95M Buy
71,941
+24,805
+53% +$1.71M 0.01% 1111
2016
Q1
$3.36M Buy
47,136
+32,049
+212% +$2.01M ﹤0.01% 1243
2015
Q4
$938K Sell
15,087
-6,933
-31% -$423K ﹤0.01% 1746
2015
Q3
$1.25M Sell
22,020
-840
-4% -$44.5K ﹤0.01% 1559
2015
Q2
$1.23M Buy
22,860
+1,307
+6% +$63.6K ﹤0.01% 1532
2015
Q1
$1.02M Buy
21,553
+3,100
+17% +$137K ﹤0.01% 1545
2014
Q4
$798K Sell
18,453
-835
-4% -$34.1K ﹤0.01% 1643
2014
Q3
$663K Sell
19,288
-357
-2% -$12.6K ﹤0.01% 1737
2014
Q2
$719K Sell
19,645
-2,502
-11% -$84.9K ﹤0.01% 1738
2014
Q1
$747K Buy
22,147
+902
+4% +$29.8K ﹤0.01% 1739
2013
Q4
$720K Buy
21,245
+1,368
+7% +$47.4K ﹤0.01% 1734
2013
Q3
$633K Buy
19,877
+282
+1% +$7.5K ﹤0.01% 1737
2013
Q2
$442K Buy
+19,595
New +$424K ﹤0.01% 1918

Other funds holding CMD

BlackRock Advisors's CMD Position: Q4 2016 in Review

BlackRock Advisors increased its Cantel Medical Corporation (CMD) stake by 65% in Q4 2016, buying an estimated $5.45M and bringing the position to 178,503 shares worth $14.1M. The position accounts for 0.01% of the portfolio, ranked #724.

BlackRock Advisors first reported a position in CMD in Q2 2013 and has held it in 15 quarters since. 234 funds tracked by Wall St. Rank hold CMD as of Q4 2016.

  • BlackRock Advisors held 178,503 shares of Cantel Medical Corporation worth $14.1M as of Q4 2016.
  • BlackRock Advisors bought 70,159 Cantel Medical Corporation shares in Q4 2016, an estimated $5.45M.
  • Cantel Medical Corporation made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #724 holding.
  • BlackRock Advisors first reported a position in Cantel Medical Corporation in Q2 2013 and has held it in 15 quarters since.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.